Bioventus Inc (BVS) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 26 2026 to Sep 27 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Bioventus Inc   (NASDAQ: BVS)


Bioventus Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Bioventus Inc's ROI in the third quarter of 2026?
Bioventus Inc achieved a return on average invested assets (ROI) of 11.27 % in its third quarter of 2026, this is above BVS's average return on investment of -7.68%.
Bioventus Inc invested over the 12 months ending in its third quarter of 2026 $563 million

Despite the deterioration in its net income, company has improved ROI compared to the second quarter of 2026.

Within the Healthcare sector 99 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 968 to 1352.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 26 2026)
III. Quarter		 (Jun 27 2026)
II. Quarter		 (Mar 28 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 27 2025)
III. Quarter
Y / Y Investment Change TTM 0.1 % -0.02 % -2.06 % -6.42 % -11.62 %
Y / Y Net Income Change TTM 547.51 % 16381.23 % - - -
Investment (TTM) in Millions 567 570 547 567 580
Return On Investment (TTM) 11.27 % 10.86 % 6.13 % 4.82 % 1.74 %
BVS's Overall Ranking # 1352 # 968 # 925 # 2324 #
Seq. Investment Change TTM -0.58 % 0.4 % -0.27 % 0.55 % -0.7 %
Seq. Net Income Change TTM 3.22 % 77.97 % 26.65 % 178.31 % 2527.35 %
Net Income (TTM) in Millions 63 61 35 27 10

BVS Company Profile >> Back to BVS Roi Comparisons >> See Annual BVS Return On Investment



Return On Investment BVS's Ranking
Within: No.
Industry # 30
Sector # 100
Overall # 1352

Return On Investment Statistics
High Average Low
10.85 %
-7.68 %
-34.89 %
(Jun 27 2026)   (Jul 01 2023)







Financial Statements
Bioventus Inc's III. Quarter Investments $ 567 Millions BVS's Balance sheet
Bioventus Inc's III. Quarter Income $ 6 Millions Quarterly BVS's Income Statement
BVS's Income by Division See BVS's Income by Division


BVS Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 567 555 683 1,092 986
Y / Y Investment Growth 2.24 % -18.78 % -37.48 % 10.75 % -
Net Income in Millions 27 -44 -196 -213 10
Y / Y Net Income Growth - - - - -
Annual Return On Investment 4.81 % -7.9 % -28.64 % -19.53 % 0.97 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 4.81 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BVS's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BVS's Competitors
Subscribers only: Roi for Bioventus Inc's Suppliers
Subscribers only: Return On Investment for BVS's Customers

Other Ratios
BVS's Roa BVS's Inventory Turnover Ratio BVS's Growth Rates BVS's Dividend Statistics
BVS's Profitability Ratios BVS's Asset Turnover Ratio BVS's Dividend Growth
BVS's Roe BVS's Valuation Ratios BVS's Financial Strength Ratios BVS's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 26 2026, within Healthcare Sector ROI
Caredx Inc   30.65 %
Zevra Therapeutics Inc   29.88 %
Acadia Pharmaceuticals Inc   26.89 %
Protalix Biotherapeutics inc   26.06 %
Standard Biotools Inc   23.91 %
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Alpha Pro Tech Ltd   13.18 %

Date modified: 2026-11-03T16:39:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.